Endocardial Fibroelastosis
Conditions
Interventions
Precise treatment of endocardial elastic hyperplasia:No
Conventional treatment:No
Sponsors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
No minimum to 12 Years
Inclusion criteria
Inclusion criteria: 1.Informed and voluntarily refer to this investigator, aged <=12 years old; 2.Promise to abide by the research procedures, and cooperate with the implementation of the whole process; 3.Patients clinical diagnosis and diagnosis of endocardial elastofibrosisin in Union Hospital, Tongji Medical College, Huazhong University of Science and Technology as a child after January 1, 2009.
Exclusion criteria
Exclusion criteria: 1.Secondary EFE; 2.EFE with noncompaction of the ventricular myocardium; 3.EFE combined with other congenital heart disease; 4.Children with incomplete data at the beginning of the onset; 5.Children considered by the investigator to be unsuitable to participate in this study.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Give up treatment or ask to leave the study; | — |
Primary
| Measure | Time frame |
|---|---|
| Left ventricular ejection fraction;Endocardial thickness ;Survival time;Death or a heart transplant; | — |
Countries
China
Contacts
Public ContactXIe Mingxing
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed